Gene · 2248
Papers2,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genes and Pathways Associated with Skeletal Sagittal Malocclusions: A Systematic Review. | Int J Mol Sci | 2021 | 34884839 | PubTator, text mining | PubMed |
| Direct SARS-CoV-2 infection of the human inner ear may underlie COVID-19-associated audiovestibular dysfunction. | Commun Med (Lond) | 2021 | 34870285 | PubTator, text mining | PubMed |
| The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment. | Front Oncol | 2021 | 34868982 | PubTator, text mining | PubMed |
| Models based on nucleic acid methylation regulators will contribute to facilitating cancer precision medicine. | BMC Med | 2021 | 34847954 | PubTator, text mining | PubMed |
| 5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer. | BMC Med | 2021 | 34836536 | PubTator, text mining | PubMed |
| Molecular Epidemiology of Multidrug-Resistant Uropathogenic Escherichia coli O25b Strains Associated with Complicated Urinary Tract Infection in Children. | Microorganisms | 2021 | 34835425 | PubTator, text mining | PubMed |
| FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance. | Cancers (Basel) | 2021 | 34830951 | PubTator, text mining | PubMed |
| Biological Significance and Targeting of the FGFR Axis in Cancer. | Cancers (Basel) | 2021 | 34830836 | PubTator, text mining | PubMed |
| Molecular Targets and Emerging Therapies for Advanced Gallbladder Cancer. | Cancers (Basel) | 2021 | 34830826 | PubTator, text mining | PubMed |
| Next-Generation Sequencing Whole-Genome Analysis for Targeted Treatment Approach of Metastatic Bartholin Gland Adenocarcinoma: An Emblematic Case Report and Review of the Literature. | Diagnostics (Basel) | 2021 | 34829431 | PubTator, text mining | PubMed |
| HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy. | Onco Targets Ther | 2021 | 34824536 | PubTator, text mining | PubMed |
| Reactions of aluminium(i) with transition metal carbonyls: scope, mechanism and selectivity of CO homologation. | Chem Sci | 2021 | 34820100 | PubTator, text mining | PubMed |
| Black raspberry restores the expression of the tumor suppressor p120ctn in the oral cavity of mice treated with the carcinogen dibenzo[a,l]pyrene diol epoxide. | PLoS One | 2021 | 34784403 | PubTator, text mining | PubMed |
| Waste-to-Energy: Production of Fuel Gases from Plastic Wastes. | Polymers (Basel) | 2021 | 34771229 | PubTator, text mining | PubMed |
| Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy. | Neurotherapeutics | 2021 | 34766257 | PubTator, text mining | PubMed |
| Biological Therapeutic Advances for the Treatment of Advanced Urothelial Cancers. | Biologics | 2021 | 34754178 | PubTator, text mining | PubMed |
| Response Stratification in the First-Line Combined Immunotherapy of Hepatocellular Carcinoma at Genomic, Transcriptional and Immune Repertoire Levels. | J Hepatocell Carcinoma | 2021 | 34737983 | PubTator, text mining | PubMed |
| Gene4HL: An Integrated Genetic Database for Hearing Loss. | Front Genet | 2021 | 34733322 | PubTator, text mining | PubMed |
| Identifying a molecular profile to predict the risk of recurrence in high-intermediate risk endometrial cancer. | Cancer Med | 2021 | 34729947 | PubTator, text mining | PubMed |
| Fibroblast Growth Factor in Diabetic Foot Ulcer: Progress and Therapeutic Prospects. | Front Endocrinol (Lausanne) | 2021 | 34721299 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2248/papers?page=28